Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives.

Authors:
Zhang XL; Li ZM; Ye JT; Lu J; Ye LL and 3 more

Journal:
Acta Pharmacol Sin

Publication Year: 2020

DOI:
10.1038/s41401-020-00519-x

PMCID:
PMC7509225

PMID:
32968208

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Pharmacol Sin

Abbreviation: Acta Pharmacol Sin

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A dual role of lysophosphatidic acid type 2 receptor (LPAR2) in nonsteroidal anti-inflammatory drug…
Hutka B; Várallyay A; László SB and 12 more (2023) - Transparency Score: 4/6
Cynaropicrin disrupts tubulin and c-Myc-related signaling and induces parthanatos-type cell death i…
Boulos JC; Omer EA; Rigano D and 6 more (2023) - Transparency Score: 3/6
GPR84 regulates pulmonary inflammation by modulating neutrophil functions.
Wang SW; Zhang Q; Lu D and 9 more (2023) - Transparency Score: 3/6
Inhibiting the transcription and replication of Ebola viruses by disrupting the nucleoprotein and V…
Ma YH; Hong X; Wu F and 7 more (2023) - Transparency Score: 3/6
MANF ameliorates DSS-induced mouse colitis via restricting Ly6C<sup>hi</sup>CX3CR1<sup>int</sup> ma…
Yang L; Shen WW; Shao W and 7 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"This work was supported by grants from the Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (2017BT01Y093), National Engineering and Technology Research Center for New Druggability Evaluation (Seed Program of Guangdong Province, 2017B090903004), Guangdong Provincial Key Laboratory of Construction Foundation (No. 2017B030314030), and the Science and Technology Strategic Cooperation Programs of Luzhou Municipal People’s Government and Southwest Medical University (No. 2017LZXNYD-P01 and 2019 LZXNYD-P01DUAN to Dayue Darrel Duan)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025